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Introduction
The frequency of multidrug-resistant (MDR) bacteria is
increasing globally. In the developing world, combination
of factors such as uncontrolled / inappropriate use of
antibiotics, limited laboratory diagnosis and failure of
infection-control strategies are commonly implicated as
cause of selection and spread of MDR organisms.1 With
ease of international travel, these organisms are moving
beyond borders at a rate faster than ever before. More
recently, a newly identified mechanism of bacterial
resistance to carbapenems, involving a metallo-beta-
lactamase (MBL) gene referred as New Delhi metallo-
beta-lactamase-1 (NDM-1) has generated a great deal of
public alarm owing to its extreme drug resistance.2
blaNDM-1enterobacteriaceae "new superbugs" first
reported in 2010 among strains from India and Pakistan
are now recognised as a global threat3,4 and have been
reported from the United States, UK, Sweden and many
other countries throughout the world.5,6 NDM-1-
producing strains are of great concern as they exhibit
resistance to almost all currently available antibiotics.
Therefore, treatment of infections caused by these strains
poses a challenge and is associated with increased
mortality.7,8 Moreover, cross-transmission of plasmids
carrying resistant gene to other gram-negative bacteria
(GNB) endemic in many developing countries (such as
Salmonella, Shigella and Cholera) is an impending threat.9
Recently there has been a concern at international level
about increasing number of carbapenem-resistant
enterobacteriacea (CRE) isolates, particularly NDM-1
positive strains, from patients returning from hospitals in
India and Pakistan.2
In Pakistan, carbapenem-resistant (CR) strains of E. coli
and Klebsiella pneumonia are emerging fast. This is
supported by unpublished clinical laboratory data of the
Aga Khan University (AKU), the largest diagnostic centre
in Pakistan, which shows an increase in CR rate from zero
in 2006 to 2% and 4% in E-coli during 2008 and 2009,
respectively.10 Similarly, CR in Klebsiella pneumonia has
risen from 8% in 2010 to 23% in hospitalised patients in
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Abstract
Objective: To find out frequency of isolation of carbapenem-resistant enterobacteriaceae and the predominantly
responsible metallo-beta-lactamasegene in a hospital setting.
Methods: The descriptive, cross-sectional study was conducted from May 2009 to June 2012 at the Aga Khan
University Hospital, Karachi, and comprised non-duplicate clinical carbapenem-resistant enterobacteriaceae
isolates obtained from different collection units across Pakistan. Kirby-Bauer disk diffusion screening of
carbapenem-resistant enterobacteriaceae was confirmed by minimum inhibitory concentration using E-test.
Polymerase chain reaction assay was performed to detect blaKPC, blaNDM-1, blaIMP, and blaVIM genes. In addition
variable number tandem repeat typing was performed on selected cluster of New Delhi metallo-beta-lactamase-1-
positive Klebsiella pneumoniae.
Results:Of the 114 carbapenem-resistant enterobacteriaceae isolates, 104(94%) tested positive for blaNDM-1 gene.
At 68(66%), Klebsiella pneumoniae was the most frequent species isolated, followed by E.coli 33(31%). Moreover,
89(78%) of the blaNDM-1 gene positive Klebsiella pneumonia isolates were from the clinical samples of patients
admitted to the critical care units and 75(66%) were from neonates and the elderly. Of the 65(67%) patients suffering
from bacteraemia and sepsis, 32(57%) had expired, of which 22(60%) were aged <1month. Variable number tandem
repeat analysis of hospital-acquired New Delhi metallo-beta-lactamase-1-positive Klebsiella pneumoniae showed
similarities between the isolates.
Conclusion: New Delhi metallo-beta-lactamase-1-positive enterobacteriaceae was found widely disseminated in
major hospitals across Pakistan. Patients at extreme ages and those in critical care units were found to be the most
affected with fatal outcomes.
Keywords:Carbapenem-resistant enterobacteriaceae, Superbugs, NDM-1, Metallobetalactamase. (JPMA66: 999; 2016)
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2011.10 We have also previously reported emergence
and spread of enterobacteriaceae with CTX-M beta-
lactamases in Pakistan.11 These rising trends are
alarming and suggest immediate attention to proper
surveillance and to ascertaining the mechanism of CR in
such isolates. The epidemiological data for NDM-1 and
other common MBLs (IMP, VIM, and KPC) in Pakistan is
severely limited.
The current study was planned to find out frequency of
isolation of CRE and the predominantly responsible MBL
gene in our hospital settings. In addition we tried to find
out clonality of hospital-acquired Klebsiella pneumonia
isolates as well as association between meropenem
minimum inhibitory concentration (MIC) and clinical
outcome in patients of different age groups.
Materials and Methods
This descriptive, cross-sectional study was conducted
from May 2009 to June 2012 at the clinical laboratory of
Aga Khan University Hospital (AKUH), Karachi, a 550-
bedfacility backed up by a state-of-the-art clinical
laboratory. The study comprised clinical isolates of CRE
that were screened by disk diffusion method and
obtained from clinical samples received for routine
culture susceptibility testing.
Extensive research was made pertaining to the
prevalence of carbapenemase-producing strains of
enterobacteriaceae in published data at national and
regional levels. However, the prevalence could not be
determined in the absence of sufficient studies, hence the
sample size was calculated according to the anticipated
frequency of 50%, with 10% of absolute precision, at a
significance level of 0.05 (i.e., 5%). The sample size was,
therefore, calculated to be 97 samples, which was
rounded up to 100.
Samples were collected from collection centres of AKUH
in different parts of the country. Only one sample was
considered per patient and all duplicates were removed.
Patients were contacted via telephone or in person to
obtain their informed consent, and complete history and
other clinical features were recorded. Isolates were
defined as community-acquired after excluding history of
exposure to healthcare settings in the last threemonths in
accordance with standard guidelines.12 The study was
reviewed and approved by the institutional ethical
committee.
Samples were inoculated on standard culture media and
incubated at 37°C.13 Gram-negative rods (GNR) isolated
from samples were identified to species level using API-20
E (bioMérieux, France). Antimicrobial susceptibilities were
determined by Kirby-Bauer disk diffusion method, in
accordance with Clinical and Laboratory Standards
Institute (CLSI) 2011 breakpoints.14 CR detected on Kirby-
Bauer disk diffusion method was confirmed by MIC
(µg/ml) using E-test (bioMérieux, Solna-Sweden). Report
of CR isolates was promptly communicated to the
clinicians for effective patient management.
Polymerase chain reaction (PCR) for detection of blaKPC,
blaNDM-1, blaIMP, and blaVIM was performed on CRE
isolates using primers as recommended.15 Variable
number tandem repeats (VNTR) typing was performed
on NDM-1-positive Klebsiella pneumonia recovered
from clinical samples of patients admitted to the
intensive care units (ICUs) of different hospitals. The
VNTR analysis was performed using eight loci as
described previously, with repeat numbers listed in the
order (A,D,E,H,I,J,K,L).16 VNTR on a few extra loci were
also performed i.e. N1,N2, N3, N4.
SPSS 19 was used for data analysis. Data was stratified for
the known effect modifiers such as age and antibiotic use,
and hence analytically controlled. To evaluate statistical
relationship between meropenem MIC of the
enterobactereaciae isolates and clinical outcome of
different age groups, p-value was calculated using
Mantel-Haenszel chi-square test.
Results
Of the 114 CRE isolates, 65(57%) were yielded from
blood cultures, 32(28%) from urine, while 9(7.9%) and
8(7%) were obtained from pus and tracheal aspirates,
respectively. Klebsiella pneumonia was the most
commonly isolated species at 73(64%), followed by
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Table-1A: Percentage distribution of Enterobacteriaceae species with respect to different Age group studied at Aga Khan University Hospital Karachi 2009-2010.
Age group <1 month 1 month-14 years 15-59 years >60 years Total
N=51 N=7 N=33 N=23 N=114
Organism Klebsiellapneumoniae 40.4% 2.6% 14% 6.1% 63.2%
E.Coli 2.6% 2.6% 13.2% 13.2% 31.6%
Citrobacter spp. - 0.9% 0.9% - 1.8%
Enterobacter spp. 0.9% - 9% 0.9% 2.6%
Serratia spp. 0.9% - -. - 0.9%
E.coli 35(31%), enterobacterspecies 4(3%),
citrobacterspecies 2(2%) and serratiamarcesences
1(1%). Only 7(6%) isolates belonged to patients from
community settings (outpatient clinics) while the
remainder were identified as hospital-acquired and
were from patients admitted to different hospitals in
major cities (10 hospitals in Sindh, two in Punjab, and
one in Balochistan).Within Sindh, 99(87%) isolates
belonged to different hospitals of Karachi (Figure).
Moreover, 89(78%) of the blaNDM-1 gene-positive
Klebsiella pneumoniae isolates were from the clinical
samples of patients admitted to the critical care units
(CCUs) and 74(65%) of the blaNDM-1strains were
isolated from patients at extremes of ages i.e. 76(67%)
from neonates and 36(32%) from the elderly (Table 1A).
In this study, 65(57%) patients suffered from bacteraemia
and sepsis as evidenced by positive blood culture. As
26(23%) patients were lost to follow-up, outcome
analysis was performed on 88(77%). Of them, 37(42%)
had expired, of which 22(59%) were aged <1 month
(Table-1B). Enterobacteriaceae isolates with meropenem
MIC ranges of =<4 µg/ml and >4µg/ml did not show
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Table-1B: Association between meropenemMIC of the Enterobactereaciae isolates and clinical outcome of different age groupsstudied at Aga Khan University Hospital Karachi during
2009-2010.
MIC ((µg/ml) Clinical Outcome Neonate N=40 Child N=5 Adult N=27 Elderly N=16 Total N=88
<=4 Expired 8 1 0 3 12
Well 9 2 6 3 20
>4 EXPIRED 14 0 6 5 25
Well 9 2 15 5 31
Statistical significance 0.391 0.414 0.145 1 0.516
MIC: Minimum inhibitory concentration.
Figure: Geographical distribution NDM-1 positive isolates.
Foot note:
Geographical representation of clinical isolates tested NDM-1 positive at the clinical laboratory of Aga Khan University Hospital 2009-2010. Coloured spots represent the AKUH sample
collection units from where samples were received, numerical represents number of isolates from that region.
NDM-1: New Delhi Metallo-beta-lactamase-1.
statistical difference in clinical outcome (p>0.05).
All CRE isolates were extended spectrum beta-Lactamase
(ESBL)-positive, hence resistant to penicillin, ampicillin,
cephalosporins and aztreonam. Amongst the
aminoglycosides, all tested isolates (100%) were resistant
to gentamicin and 10(9%) were sensitive to amikacin.
Fosfomycin was tested for 29(90.6%) urinary isolates, and
was found to be sensitive in 25(86%) of them. All of these
CRE strains were found to be susceptible to polymyxin B
by disk diffusion method.
Of all the CRE isolates, 107(94%) tested positive for
blaNDM-1 gene; 7(6%) NDM-1-negative CRE were also
found negative for other carbapenemases (blaIMP,
blaVIM, blaNDM-1) gene. Of the 15(13%) of neonatal
intensive-care unit (NICU) related isolates which were
tested for VNTR profile, 10(67%) displayed either total
similarity or profile similarity at 5 loci i.e. showing some
degree of relatedness (Table-2).
Discussion
This study indicated NDM-1 to be the commonest cause
of CR among the enterobacteriaceae isolates. Both NICUs
and adult intensive care units (AICUs) appeared to be the
common hub of these highly resistant NDM-1 carrying
Klebsiella pneumoniaand E.coli. To confirm this finding,
active surveillance-based data is required. Outbreaks of
NDM-1 carrying Klebsiella pneumoniae strains in
healthcare settings have been reported from other
countries as well.17,19 Recently, two reports of NICU-based
NDM-1 producing Klebsiella pneumonia have been
published from India and Columbia.20,21 In our study
NDM-1 carrying Klebsiella pneumonia was predominantly
from NICUs of different hospitals of Karachi, and their
VNTR typing suggested probable outbreak resulting from
cross-transmission between neonates of the same as well
as NICUs of separate hospitals due to patient transfer.
These finding are consistent with literature.20,21
Neonatal bacteraemia and sepsis remain a major cause of
death in developing countries.22 Similarly, patients at the
other end of the age scale (> 60 years) were also found to
be frequently affected. In this group, blaNDM-1 positive
E.coli was the commonest cause of urosepsis leading to
death. Due to retrospective nature of the study, risk
factors for acquisition of CRE have not been evaluated.
Other studies done on epidemic spread of MDR
organisms (acinetobacterbaumanii and pseudomonas
aeruginosa) in ICU settings of Pakistan indicated factors
such as mechanical ventilation, catheterisation,
prolonged use of antibiotics and long ICU stay23,24 as
possible risk factors.
In the current study, all expired patients were on
carbapenem treatment at the time when culture results
were communicated to the clinicians. Using carbapenem
MIC break point of 4µg/ml (Table-1B), we did not find any
statistical difference in clinical outcome of patients. One
of the limitations of this study was that statistical analysis
of precise carbapenem MIC value of isolate with the
clinical outcome was not performed; therefore it was
difficult to evaluate its significance. However, keeping in
consideration that 65% of isolates had MIC >4 µg/ml
(Table-1B) and 30% of isolates had MIC >32 µg/ml, our
findings caution against sole use of carbapenem as
empirical coverage for suspected gram-negative
infections (GNI) in NICUs and AICUs. Treatment options for
the infections due to NDM-1 positive isolates are severely
limited. In our study polymyxin B was the only antibiotic
to which blaNDM-1 positive isolates was susceptible.25
While use of polymyxins in such a situation is encouraged,
J Pak Med Assoc
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Table-2: VNTR profile of 28 Klebsiellapneumoniae isolates tested at Aga Khan
University Hospital Karachi 2009-2010.
VNTR Isolate Critical VNTR profile
matching No. Care Setting (A,D,E,H,I,J,K,L,N1,N2N3N4)
Identical profile B1 SCU 5387---44413.5
A1 NICU 5387---44413.5
5 loci matching A2 NICU 53-1-0-44413.5
A3 NICU -------44413.5
A4 NICU 533401254213.5
A5 NICU 5386--244413.5
A6 NICU 5251-9144413.5
A7 SCU 533-3--42413.5
A8 NICU 735732-42413.5
A9 NICU 53510--44-13.5
A10 NICU 232--6233413.5
A11 NICU 5387---34413.5
3 loci matching A12 NICU 233--7-43413.5
A13 NICU 723530-41413.5
A14 ICU 5351-2441
A15 SCU 62-13124441-
A16 NICU 12--3--7--43.5
A17 SCU -4.5
B2 ICU 53373--4241-
A18 ICU -2-----4--4-
A19 SCU 10.5
A20 SCU 13313--42-1-
A21 NICU 12--3--4-443.5
A22 SCU 10.5
A23 NICU -23530143
Isolate number corresponds to A1-23=Hospitals of Karachi, B1-B2= hospitals outside Karachi.
VNTR: variable number tandem repeat.
NICU: Neonatal intensive-care unit.
SCU: Special care unit.
ICU: Intensive care unit.
prompt de-escalation is strongly advised to avoid losing
this only effective drug currently available in Pakistan.26
Seven per cent of the isolates yielded from patients who
had not had any exposure to the hospitals in last three
months. All of them were residents of Karachi. This is an
alarming situation and stresses the need for proactive
surveillance.27 Of particular interest was a cohort of
isolates (6%) that were negative for blaNDM-1 and also
did not show PCR signals for other enzymes (blaIMP, VIM,
NDM-1). Other mechanism of CR such as alteration in
outer membrane porins and efflux pumps need to be
investigated.
Our findings also highlight the need for rapid methods,
for the detection of NDM-1 and other emerging resistance
mechanisms in the clinical laboratories. This is essential
for effective treatment, infection control measure and
active surveillance. Phenotypic screening methods such
as Modified Hodge test might miss NDM-1 gene-positive
isolates due to variable sensitivity and specificity.28 While
advancedcare-testing methods would be the ultimate
turning point in the global control of these superbugs,
simple phenotypic methods as opposed to technically-
advanced molecular-based tests (difficult to
maintain/sustain in developing countries) are the need of
time to curtail this global threat.
Small sample size was one of the limitations of this study.
Therefore, its VNTR findings cannot be generalised and
further studies are warranted.
Conclusion
NDM-1-positive enterobacteriaceae are widely
disseminated in the hospitals of major cities of Pakistan.
We recommend caution against sole use of carbapenem
as empirical coverage for suspected GNIs in NICUs and
AICUs. There is a need for rapid methods for the early
detection of NDM-1 and other emerging resistance
mechanisms to reduce mortality.
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